arrow_back Back Filing freshness 40-F FY 2025 SEC EDGAR

download Export Data

Cresco Labs Inc.

CRLBF

— Price unavailable

6 Visible periods

29 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Cresco Labs Inc. faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap —

Dividend Yield —

Revenue Growth -9.5% ↘

Op. Margin -4.3% ↘

ROIC -5.4% ↘

FCF / Share $0.11 ↘

Trailing P/E —

Price / Book —

FCF Yield —

Debt / Equity 1.26

info Valuation on last close.

6-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$655.85M

↓ -9.5% —

Net Income Profit after all expenses

$-135.41M

↓ -81.9% —

Operating Margin Operating profit as % of sales

-4.3%

↓ -128.8% 21th

FCF / Share Free cash flow per share

$0.11

↓ -67.5% —

Long-Term Debt Long-term obligations

$417.10M

↓ -9.5% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Debt to EquityDebt to Equity is concerning (bottom quartile)
Operating Margin (%)Operating Margin (%) is in the bottom quartile
Profit Margin (%)Profit Margin (%) is in the bottom quartile
Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability ↑

Returns ↓

Financial Health ↑

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 4 metrics

Metric	FY 2025 Dec 31, 2025 40-F ↗	FY 2024 Dec 31, 2024 40-F ↗	FY 2023 Dec 31, 2023 40-F ↗	FY 2022 Dec 31, 2022 40-F ↗	FY 2021 Dec 31, 2021 40-F ↗	FY 2020 Dec 31, 2020 40-F ↗
Revenue Growth YoY (%)	-9.5% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-289%)	-6.0% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-221%)	—	—	—	—
EPS Growth YoY (%)	-72.7% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	59.3% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—
Net Income Growth YoY (%)	-81.9% Weak ↓ Weak Declining Year-over-year change in net income	57.6% Excellent ↑ Excellent Improving Year-over-year change in net income	18.7% Good ↑ Good Improving Year-over-year change in net income	27.3% Excellent Excellent Year-over-year change in net income	-220.0% Weak Weak Year-over-year change in net income	—
FCF Growth YoY (%)	-67.5% Weak Weak Year-over-year change in free cash flow	3231.4% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 40-F ↗	FY 2024 Dec 31, 2024 40-F ↗	FY 2023 Dec 31, 2023 40-F ↗	FY 2022 Dec 31, 2022 40-F ↗	FY 2021 Dec 31, 2021 40-F ↗	FY 2020 Dec 31, 2020 40-F ↗
Operating Margin (%) (%)	-4.3% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-128%)	14.8% Fair Fair Operating income as a percentage of revenue Optimal: > 15% vs Sector: At sector avg	-11.4% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-176%)	—	—	—
Effective Tax Rate (%) (%)	-46.8% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-469.8% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	-22.4% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—
Profit Margin (%) (%)	-20.6% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-306%)	-10.3% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-203%)	-22.8% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-328%)	—	—	—
FCF Margin (%) (%)	5.8% Caution ↓ Caution Declining Free cash flow as a percentage of revenue Optimal: > 10%	15.6% Good Good Free cash flow as a percentage of revenue Optimal: > 10%	0.4% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—
FCF / Net Income (x)	-0.28x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	-1.52x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	-0.02x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 40-F ↗	FY 2024 Dec 31, 2024 40-F ↗	FY 2023 Dec 31, 2023 40-F ↗	FY 2022 Dec 31, 2022 40-F ↗	FY 2021 Dec 31, 2021 40-F ↗	FY 2020 Dec 31, 2020 40-F ↗
Return on Invested Capital (%)	-5.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	65.3% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	-10.7% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—	—
Return on Capital (%) (%)	-2.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	7.9% Fair Fair Operating profit relative to total assets Optimal: > 10%	-6.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—
Return on Common Equity (%) (%)	-39.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-431%)	-15.7% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-231%)	-34.7% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-389%)	—	—	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 40-F ↗	FY 2024 Dec 31, 2024 40-F ↗	FY 2023 Dec 31, 2023 40-F ↗	FY 2022 Dec 31, 2022 40-F ↗	FY 2021 Dec 31, 2021 40-F ↗	FY 2020 Dec 31, 2020 40-F ↗
Debt to Equity (x)	1.26x Caution ↑ Caution Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+151%)	1.00x Fair Fair Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+99%)	1.01x Caution Caution Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+102%)	—	—	—
Interest Coverage (x)	-0.67x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	2.83x Caution Caution Operating income divided by interest expense Optimal: > 5x	-2.02x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—
Net Debt (USD)	$369.98M	$335.12M	$406.10M	—	—	—
Debt / EBITDA (x)	20.65x Weak ↑ Weak Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	2.84x Fair Fair Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-20.13x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 40-F ↗	FY 2024 Dec 31, 2024 40-F ↗	FY 2023 Dec 31, 2023 40-F ↗	FY 2022 Dec 31, 2022 40-F ↗	FY 2021 Dec 31, 2021 40-F ↗	FY 2020 Dec 31, 2020 40-F ↗
Revenue per Share (USD)	$1.85	$2.10	$2.38	—	—	—
Basic EPS, GAAP (USD)	$-0.38	$-0.22	$-0.54	—	—	—
Free Cash Flow per Share (USD)	$0.11	$0.33	$0.01	—	—	—
Book Value per Share (USD)	$0.96	$1.37	$1.56	—	—	—
Tangible Book Value per Share (USD)	$-0.40	$-0.30	$-0.22	—	—	—
Basic Weighted Avg Shares (shares)	355.01M	345.47M	323.82M	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 40-F ↗	FY 2024 Dec 31, 2024 40-F ↗	FY 2023 Dec 31, 2023 40-F ↗	FY 2022 Dec 31, 2022 40-F ↗	FY 2021 Dec 31, 2021 40-F ↗	FY 2020 Dec 31, 2020 40-F ↗
Working Capital (USD)	$159.09M	$199.92M	$77.84M	—	—	—
LT Debt (USD)	$417.10M	$460.75M	$497.71M	—	—	—
Total Equity (USD)	$340.45M	$474.85M	$505.69M	—	—	—

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 40-F ↗	FY 2024 Dec 31, 2024 40-F ↗	FY 2023 Dec 31, 2023 40-F ↗	FY 2022 Dec 31, 2022 40-F ↗	FY 2021 Dec 31, 2021 40-F ↗	FY 2020 Dec 31, 2020 40-F ↗
Sales/Revenue/Turnover (USD)	$655.85M	$724.34M	$770.88M	—	—	—
Depreciation Expense (USD)	$48.71M	$59.10M	$62.51M	—	—	—
Net Income, GAAP (USD)	$-135.41M	$-74.44M	$-175.52M	$-215.84M	$-296.83M	$-92.77M
Operating Cash Flow (USD)	$72.89M	$132.48M	$58.56M	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 6 years · 6 quarters

Cresco Labs Inc.

Analytical Summary

6-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare CRLBF with peers